Ireland
--:--IST
Latest
Clinical Trials in Canada / NCT07673770
Recruiting Not applicable

Brain Wave Informed Non-invasive Brain Stimulation: Improving Neural Networks of Working Memory in Dementia: a Proof-of-concept Study

NCT07673770 · tracked via the Priya Life Science Canada tracker
Phase
Not applicable
Started
2026-07-07
Last updated
2026-07-07

Condition(s) studied

DementiaAlzheimer s Disease

Investigational drug(s) / intervention(s)

EEG-triggered TMS

EEG-triggered TMS: This intervention involves delivering transcranial magnetic stimulation (TMS) to the dorsolateral prefrontal cortex (dlPFC) during working memory maintence timed to a specific electroencephalography (EEG) phase from the temporal cortex. The intervention is attempting to facilitate improved communication between the dlPFC and temporal cortex to improve working memory in people living with dementia.

Study summary

Working memory helps us hold information for a short time so one can think and make decisions. It keeps thoughts on track. As one gets older, working memory gets weaker. In people with dementia, it gets much worse, making it harder to talk with others, follow directions, or remember things like shopping lists.

This may happen because brain waves that support working memory fall out of sync. Researchers can see these brain waves using a test called EEG. In this study, the investigators will try to get these brain waves back in sync using a safe, non-invasive form of brain stimulation called transcranial magnetic stimulation (TMS), and will time it to each person's brain waves to make it more effective. The goal is to improve working memory in people with dementia. If successful, dementia patients may be able to be more independent taking pressure off their families.

Eligibility

Sex
ALL
Min age
55 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Individuals must be diagnosed with Alzheimer's Disease or related dementias by a clinician. * Individuals must exhibit adequate oral communication skills and cognitive function sufficient to obtain a score above 10 on the MMSE * Instructions will be delivered in English; therefore participants must demonstrate an understanding of instruction provided in English. * Individuals must be at least 55 years or older Exclusion Criteria: * Contraindications to TMS; presence of a pacemaker, metal/electrical/magnetic implants not including titanium, known history of untreated or uncontrolled psychological disorders, pregnancy, history of seizure or diagnoses of epilepsy, are taking any prescription medications that increase the risk of seizure. * Allergy to rubbing alcohol, which is needed to prepare electromyography for TMS

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Ivor Wynne Center Hamilton Ontario Recruiting

More McMaster University trials in Canada

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07673770 on ClinicalTrials.gov ↗ ← All trials in Canada